Table 1. Demographic and clinical data of stroke patients.

Patient number	Gender	Age (years)	Months poststroke	Affected side	Lesion location	Lesion volume (voxels)	UE_FMT	WE_FMT	Medical history
001	F	65	63	R	CR and IC	669	62	94	HG, HL
002	M	62	52	R	IC	470	66	100	DM, HL
003	F	63	48	R	CR	470	65	98	HBP
004	F	52	64	R	BG	1034	65	99	None
005	M	53	37	R	CR and IC	1495	62	95	HBP, HL
006	M	65	37	R	CR	143	66	98	DM, HL
007	M	59	52	L	CR	1425	64	98	DM, HL
008	M	49	40	L	CR	450	65	98	DM, HG
009	M	60	40	L	CR	104	66	100	HG, HL
010	F	72	52	R	CR	329	65	98	HG
011	F	55	24	L	Th	297	66	100	HG
012	M	49	24	R	BG	229	66	100	HG
013	M	42	24	L	Th	417	66	100	HG, DM, TIA, HL
014	M	50	20	L	CR	375	66	100	HG, TIA, HL
015	M	52	22	L	CR	299	66	100	HL
016	M	58	52	L	IC	222	66	100	HBP
017	M	65	20	R	CR	609	65	99	HBP, HG
018	F	63	14	R	Th	129	66	100	DM
019	M	55	12	L	IC and BG	414	66	100	HBP, HL
020	M	47	13	L	CR	302	66	100	HBP, DM, HL
021	M	58	14	R	BG	2742	66	100	HG
022	M	63	13	L	CR	184	66	100	TIA, HL, DM
023	M	45	12	R	IC	250	66	100	HG, DM, HL
024	M	49	14	R	CR and IC	251	64	96	HG, HL
025	F	53	12	L	CR and BG	651	66	99	HBP

BG, basal ganglion; CR, corona radiate; DM, diabetes mellitus; HBP, high blood pressure; HG, hyperglycemia; HL, hyperlipidemia; IC, internal capsule; L, left; R, right; Th, thalamus; TIA, transient ischemic attack; UE_FMT, upper extremity Fugl-Meyer test; WE_FMT, whole extremity Fugl-Meyer test.